Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Stazi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Neurobiology|September 11, 2020
Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's DiseaseMartina Stazi, Oliver Wirths
Behavioural Brain Research|October 7, 2020
Physical activity and cognitive stimulation ameliorate learning and motor deficits in a transgenic mouse model of Alzheimer's diseaseMartina Stazi, Oliver Wirths
Neurobiology of Aging|July 15, 2018
An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's diseaseGrazia Rutigliano, Martina Stazi, Ottavio Arancio, et al.
International Journal of Molecular Sciences|February 11, 2023
A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer's Disease Mouse ModelMartina Stazi, Silvia Zampar, Hans-Wolfgang Klafki, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 8, 2022
Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 miceMartina Stazi, Silvia Zampar, Madeleine Nadolny, et al.
Scientific Reports|February 17, 2017
Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse modelChiara Criscuolo, Veronica Fontebasso, Silvia Middei, et al.
Cellular and Molecular Life Sciences : CMLS|December 16, 2021
Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesisMartina Stazi, Sandra Lehmann, M Sadman Sakib, et al.
Alzheimer'S Research & Therapy|December 12, 2018
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's diseaseHedieh Shahpasand-Kroner, Hans-W Klafki, Chris Bauer, et al.
Alzheimer'S Research & Therapy|October 6, 2017
N-truncated Aβ<sub>4-x</sub> peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse modelsOliver Wirths, Susanne Walter, Inga Kraus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Neurobiology|September 11, 2020
Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's DiseaseMartina Stazi, Oliver Wirths
Behavioural Brain Research|October 7, 2020
Physical activity and cognitive stimulation ameliorate learning and motor deficits in a transgenic mouse model of Alzheimer's diseaseMartina Stazi, Oliver Wirths
Neurobiology of Aging|July 15, 2018
An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's diseaseGrazia Rutigliano, Martina Stazi, Ottavio Arancio, et al.
International Journal of Molecular Sciences|February 11, 2023
A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer's Disease Mouse ModelMartina Stazi, Silvia Zampar, Hans-Wolfgang Klafki, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 8, 2022
Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 miceMartina Stazi, Silvia Zampar, Madeleine Nadolny, et al.
Scientific Reports|February 17, 2017
Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse modelChiara Criscuolo, Veronica Fontebasso, Silvia Middei, et al.
Cellular and Molecular Life Sciences : CMLS|December 16, 2021
Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesisMartina Stazi, Sandra Lehmann, M Sadman Sakib, et al.
Alzheimer'S Research & Therapy|December 12, 2018
A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's diseaseHedieh Shahpasand-Kroner, Hans-W Klafki, Chris Bauer, et al.
Alzheimer'S Research & Therapy|October 6, 2017
N-truncated Aβ<sub>4-x</sub> peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse modelsOliver Wirths, Susanne Walter, Inga Kraus, et al.
Pageof 1